Chronic constipation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients who are able to provide informed consent for participation in this study 2) At the time of study participation, the patient is taking or using medication for constipation prescribed by a medical facility for chronic constipation.
Exclusion criteria
Exclusion criteria: 1)Patients who work for any of the following organizations (pharmaceutical or medical devices industry, advertising and broadcasting industry, survey and consulting services industry) 2) aged <18 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Work productivity outcomes (absenteeism, presenteeism, total work productivity impairment, total activity impairment) 2) Correlation between total work productivity impairment and each constipation symptom 3) Correlation between total activity impairment and each constipation symptom 4) Work productivity outcomes (absenteeism, presenteeism, total work productivity impairment, total activity impairment) by the presence of each constipation symptom 5) Correlation between total work productivity impairment and satisfaction with constipation treatment 6) Correlation between total activity impairment and satisfaction with constipation treatment 7) Satisfaction with constipation treatment 8) Correlation between satisfaction with constipation treatment and each constipation symptom 9) Change in the degree of work productivity loss/activity loss from before the start of treatment 10) Subgroup analysis by patient background | — |
Countries
Japan
Contacts
Mochida Pharmaceutical Co., Ltd. Medical Affairs